Chronic retroviral infection of mice promotes tumor development, but CD137 agonist therapy restores effective tumor immune surveillance

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Cancer Immunology and Immunotherapy

• Publication date

  2019-01-11

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00262-019-02300-4PMID 30635687PMCID PMC11028158
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies.

  2018cited by this paper
• 4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses

  2018cited by this paper
• Fas Ligand-mediated cytotoxicity of CD4+ T cells during chronic retrovirus infection

  2017cited by this paper
• Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibody

  2016cited by this paper
• Rationale for anti-OX40 cancer immunotherapy.

  2016cited by this paper
• OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential

  2016cited by this paper
• CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity

  2016cited by this paper
• Anti-CD137 monoclonal antibodies and adoptive T cell therapy: a perfect marriage?

  2016cited by this paper
• Rationale for anti-CD137 cancer immunotherapy.

  2016cited by this paper
• Boosting Cancer Immunotherapy with Anti-CD137 Antibody Therapy

  2015cited by this paper
• Malignancies in HIV/AIDS: from epidemiology to therapeutic challenges

  2014cited by this paper
• How Do CD4+ T Cells Detect and Eliminate Tumor Cells That Either Lack or Express MHC Class II Molecules?

  2014cited by this paper
• CD8+ T Cells Are Essential for Controlling Acute Friend Retrovirus Infection in C57BL/6 Mice

  2014cited by this paper
• Combining Regulatory T Cell Depletion and Inhibitory Receptor Blockade Improves Reactivation of Exhausted Virus-Specific CD8+ T Cells and Efficiently Reduces Chronic Retroviral Loads

  2013cited by this paper
• Immunotherapy of melanoma with the immune costimulatory monoclonal antibodies targeting CD137

  2013cited by this paper
• Mortality in well controlled HIV in the continuous antiretroviral therapy arms of the SMART and ESPRIT trials compared with the general population

  2013cited by this paper
• CD4+ T Cells Develop Antiretroviral Cytotoxic Activity in the Absence of Regulatory T Cells and CD8+ T Cells

  2013cited by this paper
• Natural regulatory T cells inhibit production of cytotoxic molecules in CD8+ T cells during low-level Friend retrovirus infection

  2013cited by this paper
• Immunotherapy of Cancer with 4-1BB

  2012cited by this paper
• Tumor-specific CD4+ T cells develop cytotoxic activity and eliminate virus-induced tumor cells in the absence of regulatory T cells

  2012cited by this paper
• Distinct roles of CD4+ T cell subpopulations in retroviral immunity: lessons from the Friend virus mouse model

  2011cited by this paper
• Transient depletion of regulatory T cells in transgenic mice reactivates virus-specific CD8+ T cells and reduces chronic retroviral set points

  2011cited by this paper
• Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts

  2010cited by this paper
• Adjuvant Therapy With Agonistic Antibodies to CD134 (OX40) Increases Local Control After Surgical or Radiation Therapy of Cancer in Mice

  2010cited by this paper
• OX40 costimulation can abrogate Foxp3+ regulatory T cell‐mediated suppression of antitumor immunity

  2009cited by this paper
• The regulatory T-cell response during acute retroviral infection is locally defined and controls the magnitude and duration of the virus-specific cytotoxic T-cell response.

  2009cited by this paper
• T-bet and Eomesodermin Play Critical Roles in Directing T Cell Differentiation to Th1 versus Th171

  2008cited by this paper
• Multi-layered action mechanisms of CD137 (4-1BB)-targeted immunotherapies.

  2008cited by this paper
• Eradication of established renal cell carcinoma by a combination of 5‐fluorouracil and anti‐4‐1BB monoclonal antibody in mice

  2008cited by this paper
• CD8+ T-Cell Dysfunction due to Cytolytic Granule Deficiency in Persistent Friend Retrovirus Infection

  2005cited by this paper
• Foxp3 Expressing CD4+CD25high Regulatory T Cells Are Overrepresented in Human Metastatic Melanoma Lymph Nodes and Inhibit the Function of Infiltrating T Cells1

  2004cited by this paper
• Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome

  2004cited by this paper
• Functional impairment of CD8(+) T cells by regulatory T cells during persistent retroviral infection.

  2004cited by this paper
• Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin

  2003cited by this paper
• Immunosuppression by CD4+ regulatory T cells induced by chronic retroviral infection

  2001cited by this paper
• Ox-40 ligand: a potent costimulatory molecule for sustaining primary CD4 T cell responses.

  1998cited by this paper
• Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors

  1997cited by this paper
• Identification of a gag-encoded cytotoxic T-lymphocyte epitope from FBL-3 leukemia shared by Friend, Moloney, and Rauscher murine leukemia virus-induced tumors

  1996cited by this paper
• Multiplicity of virus-encoded helper T-cell epitopes expressed on FBL-3 tumor cells

  1993cited by this paper
• The Roles of CD8+ and CD4+ Cells in Tumor Rejection

  1989cited by this paper
• The G (Gross) leukemia antigen.

  1965cited by this paper

• T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities.

  2026cites this paper
• Structure of PD1 and its mechanism in the treatment of autoimmune diseases

  2023cites this paper
• Cytotoxic CD4+ T cells in chronic viral infections and cancer

  2023cites this paper
• Immunotherapy-induced cytotoxic T follicular helper cells reduce numbers of retrovirus-infected reservoir cells in B cell follicles

  2023cites this paper
• Friend retrovirus studies reveal complex interactions between intrinsic, innate and adaptive immunity

  2019cites this paper